Skip to main content
Log in

Review of West Syndrome: Concerns on Optimum Dose of Adrenocorticotrophic Hormone

  • Letter to the Editor
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

The Original Article was published on 31 October 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. D’Alonzo R, Rigante D, Mencaroni E, Esposito S. West Syndrome: a review and guide for paediatricians. Clin Drug Invest. 2018;38(2):113–24.

    Article  Google Scholar 

  2. Vaddi VK, Sahu JK, Dhawan SR, Suthar R, Sankhyan N. Knowledge, attitude and practice (KAP) study of pediatricians on infantile spasms. Indian J Pediatr. 2018. https://doi.org/10.1007/s12098-018-2630-3.

    Article  PubMed  Google Scholar 

  3. Hrachovy RA, Frost JD, Glaze DG. High-dose, long-duration versus low-dose, short-duration corticotropin therapy for infantile spasms. J Pediatr. 1994;124(5 Pt 1):803–6.

    Article  PubMed  CAS  Google Scholar 

  4. Baram TZ, Mitchell WG, Tournay A, Snead OC III, Hanson RA, et al. High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study. Pediatrics. 1996;97(3):375.

    PubMed  PubMed Central  CAS  Google Scholar 

  5. Shu X-M, Li J, Zhang G-P, Mao Q. A comparative study of conventional dose and low dose adrenocorticotrophic hormone therapy for West syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2009;11(6):445–8.

    PubMed  Google Scholar 

  6. Yanagaki S, Oguni H, Hayashi K, Imai K, Funatuka M, Tanaka T, et al. A comparative study of high-dose and low-dose ACTH therapy for West syndrome. Brain Dev. 1999;21(7):461–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jitendra K. Sahu.

Ethics declarations

Conflict of interest

The all authors declare that they have no conflicts of interest to disclose with regard to this letter.

Funding

This letter did not receive any financial support from funding agencies in the public, private, or not-for-profit sectors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sahu, J.K., Vaddi, V.K. & Negi, S. Review of West Syndrome: Concerns on Optimum Dose of Adrenocorticotrophic Hormone. Clin Drug Investig 38, 563–564 (2018). https://doi.org/10.1007/s40261-018-0640-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40261-018-0640-6

Navigation